What is the recommended management for a 37‑year‑old woman with bilateral pars defects and a 13 mm anterolisthesis of L5 on S1 (Grade I isthmic spondylolisthesis) and moderate disc space narrowing at L4‑L5 and L5‑S1?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 37-Year-Old Female with Bilateral Pars Defects and Grade I Isthmic Spondylolisthesis

This patient requires surgical decompression with instrumented fusion at L5-S1 after documented failure of comprehensive conservative management for at least 3–6 months. 1, 2, 3

Surgical Indication Criteria

Bilateral pars defects with 13 mm anterolisthesis (Grade I isthmic spondylolisthesis) constitute documented spinal instability—a Grade B indication for fusion in addition to decompression. 1, 2, 3

Key Diagnostic Findings Supporting Fusion

  • Bilateral pars interarticularis defects represent structural failure of the posterior elements that normally resist anterior vertebral displacement, creating inherent biomechanical instability. 4, 5

  • 13 mm anterolisthesis (approximately 25–30% slip on a standard vertebral body) confirms Grade I spondylolisthesis and documents that the instability is already producing measurable displacement. 4, 5

  • Moderate disc space narrowing at L4-L5 and L5-S1 indicates advanced degenerative changes that compound the instability and increase the risk of symptom progression. 4, 6

  • Class II evidence demonstrates that 96% of patients with spondylolisthesis and stenosis achieve excellent/good outcomes with decompression plus fusion, versus only 44% with decompression alone. 1, 2, 3

Mandatory Conservative Management Before Surgery

Before proceeding to surgery, this patient must complete a minimum of 3–6 months of comprehensive conservative therapy, including:

  • Formal supervised physical therapy for at least 6 weeks, focusing on flexion-based exercises (abdominal strengthening, posterior pelvic tilts) rather than extension exercises, as flexion protocols produce superior outcomes in isthmic spondylolisthesis. 1, 6

  • Trial of neuropathic pain medications (gabapentin or pregabalin) if radicular symptoms are present. 1

  • Anti-inflammatory medications and activity modification. 5, 6

  • Transforaminal epidural steroid injections may provide short-term relief (typically <2 weeks) but are not a substitute for structured physical therapy. 1, 5

Failure of this conservative regimen—defined as persistent disabling symptoms, functional impairment, or neurologic compromise—establishes medical necessity for surgical intervention. 1, 3

Recommended Surgical Approach

Transforaminal lumbar interbody fusion (TLIF) at L5-S1 with pedicle screw instrumentation is the appropriate technique for Grade I isthmic spondylolisthesis. 1, 3, 5

Rationale for TLIF with Instrumentation

  • TLIF provides fusion rates of 92–95% while allowing simultaneous neural decompression through a unilateral approach that minimizes dural retraction. 1, 3

  • Pedicle screw fixation improves fusion success rates from 45% to 83% (p=0.0015) compared to non-instrumented fusion in patients with spondylolisthesis. 1, 2

  • Interbody fusion restores disc height, improves foraminal dimensions, and places graft within the load-bearing anterior column, providing superior biomechanical stability. 1, 5

  • Combined anterior-posterior (360-degree) fusion achieves fusion rates of 89–95% in patients with degenerative disc disease and spondylolisthesis. 1

Bone Graft Options

  • Local autograft harvested during laminectomy combined with allograft provides equivalent fusion outcomes and avoids iliac crest donor-site morbidity (which occurs in 58–64% of patients at 6 months). 1

  • Grade B evidence supports rhBMP-2 as a bone graft extender when performing TLIF with structural interbody graft, though surgeons should use hydrogel sealant to shield the exiting nerve root (reducing radiculitis incidence from 20.4% to 5.4%). 1

Critical Decision Points: When Fusion Is Mandatory vs. Optional

Fusion Is Mandatory When:

  • Any degree of spondylolisthesis is present on static imaging (as in this case). 1, 2, 3

  • Dynamic flexion-extension radiographs demonstrate >3–4 mm translation or >10 degrees angulation, confirming dynamic instability. 2

  • Extensive bilateral facetectomy (>50% facet removal) is required for adequate neural decompression, creating iatrogenic instability risk of approximately 37.5%. 2

Fusion Is Not Indicated When:

  • Isolated foraminal stenosis without spondylolisthesis or instability is present—decompression alone (foraminotomy) achieves 97% symptom recovery. 1

  • Isolated disc herniation without instability—Level III evidence shows no significant difference between discectomy alone versus discectomy with fusion. 1

Expected Outcomes and Complications

Patients with isthmic spondylolisthesis treated with decompression plus fusion report:

  • 93–96% excellent/good outcomes with statistically significant reductions in back pain (p=0.01) and leg pain (p=0.002) compared to decompression alone. 1, 2, 3

  • 93% patient satisfaction rates with significant improvements in ability to perform activities, participate socially, sit, and sleep. 2

Complication rates for TLIF procedures are approximately 31–33.6%, including cage subsidence, new nerve root pain, and hardware issues (most not requiring immediate intervention). 1

Common Pitfalls to Avoid

  • Do not perform decompression alone in the presence of any degree of spondylolisthesis—preoperative spondylolisthesis is a documented risk factor for 5-year clinical and radiographic failure, with up to 73% risk of progressive slippage after decompression alone. 2

  • Do not proceed to surgery without documented failure of formal supervised physical therapy for at least 6 weeks—this is a critical deficiency that renders the procedure not medically necessary. 1

  • Do not extend fusion to L4-L5 unless that level independently meets fusion criteria (documented instability, spondylolisthesis, or anticipated iatrogenic instability from extensive decompression). 1, 2

  • Avoid extension-based exercise programs—flexion protocols produce superior outcomes in isthmic spondylolisthesis, with only 19% reporting moderate/severe pain at 3 years versus 67% in extension groups. 6

References

Guideline

Medical Necessity of Lumbar Fusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lumbar Spine Fusion for Spinal Stenosis with Neurogenic Claudication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Spondylolisthesis L4-L5 with Radiculopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Low-grade isthmic/lytic spondylolisthesis in adults.

Instructional course lectures, 2003

Research

Isthmic spondylolisthesis in adults… A review of the current literature.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2022

Research

Evaluation and conservative management of spondylolisthesis.

Journal of back and musculoskeletal rehabilitation, 1993

Related Questions

What is the diagnosis and treatment for Spondylolisthesis (slippage of a vertebra)
What is the initial treatment for a patient with grade 1 L4 (lumbar 4) isthmic spondylolisthesis?
Is left L4-5 and L5-S1 laminectomy with left L5-S1 Transforaminal Lumbar Interbody Fusion (TLIF) and L4-S1 posterior instrumented fusion medically necessary for a patient with spondylolisthesis and pars defect, presenting with back pain, radiculopathy, and difficulty with transitions, bending, sitting, and squatting?
Does weight loss improve functional outcomes and reduce slippage in an overweight or obese patient with spondylolisthesis and hyperlordosis?
What is the recommended treatment for an elderly male patient with grade 1 spondylolisthesis of L5 on S1, lipping at L2, L3, and L4, and partial lumbarization of S1?
Can a premenopausal woman taking trazodone for depression or insomnia safely take Addyi (flibanserin) together?
What is the Golde score, how is it calculated on bronchoalveolar lavage fluid, and what threshold indicates clinically significant alveolar hemorrhage?
What are the possible causes of an elevated serum creatinine level?
Can a premenopausal woman with hypoactive sexual desire disorder safely take Addyi (flibanserin) together with gabapentin?
What is the pharmacologic target of inhaled corticosteroids?
What is the recommended acute treatment for an adult with an acute migraine attack, including first‑line triptans, anti‑emetics, NSAIDs, and alternatives for contraindications such as uncontrolled hypertension, cardiovascular disease, pregnancy, or drug allergies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.